reference/36589955

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36589955

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article
issn	0928-0987
pageRange	106598-
publicationName	European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
startingPage	106598
bibliographicCitation	Yang XM, Yang Y, Yao BF, Ye PP, Xu Y, Peng SP, Yang YM, Shu P, Li PJ, Li S, Hu HL, Li Q, Song LL, Chen KG, Zhou HY, Zhang YH, Zhao FR, Tang BH, Zhang W, Zhang XF, Fu SM, Hao GX, Zheng Y, Shen JS, Xu YC, Jiang XR, Zhang LK, Tang RH, Zhao W. A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects. Eur J Pharm Sci. 2023 Dec 01;191():106598. doi: 10.1016/j.ejps.2023.106598. PMID: 37783378.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a18fea1ed00a5e20c561934dcd61bf1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e15c36bd3918f92e3a6b13f045b9cb0c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9398a1a8929c3ca98819900c79acc9fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb7c862456feba43fb0b9a7a11a067ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19ee36182c22d98ba2bc468246db2222 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66eab64a93fc503b1d6a3849691ad7bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71f09b1ec5bf46d2be6da1eafd22f47e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db97d5185b8bb3c2691fd00072fc5161 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d2332609cd9f61c2584c807765230c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_558a937f904694a03f4bea35a85dbfc6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63fbe64fb5cd6795a80b5002a407ce41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40ebff214fdd4758dd567bed27b97aa7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa080d133e752c0eab335a8e8de7afa3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eac613d70dd84371628b30c9993b45f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8953874a7c8561a77bc0b03f78b679f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1780ae0219a1b642514bd00f4ec276c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1830-338X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4add6c4c2c42d0fa776a925e97593ab4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99c0252cddc25cf5d58c7f3b0cc86cf1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb8e6e14d0d62c11f37a5ed7b560af75 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7754d5f64f6ddb8b065e0217ca72ac87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ec817711eb305c50103ac4f1b9637f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b0623a2844c54add82b6198a1d713b1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c36dee71e0c80cbf6018a74524aab40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64f899f9d0163bf1c9d3343cbe439146 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66a0eff99d9e77db324961ba30647a70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7659b7b0af0c635186012a4ae38359da http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3204309c751a41a8ea976d699cdab028 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
date	2023-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/j.ejps.2023.106598 https://pubmed.ncbi.nlm.nih.gov/37783378
isPartOf	https://portal.issn.org/resource/ISSN/0928-0987 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21091
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects
discusses	http://id.nlm.nih.gov/mesh/M0001518 http://id.nlm.nih.gov/mesh/M0007520 http://id.nlm.nih.gov/mesh/M0028918 http://id.nlm.nih.gov/mesh/M0017845
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000086382 http://id.nlm.nih.gov/mesh/D011480Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000086402 http://id.nlm.nih.gov/mesh/D019438Q000627 http://id.nlm.nih.gov/mesh/D004791 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D064368 http://id.nlm.nih.gov/mesh/D000998Q000009 http://id.nlm.nih.gov/mesh/D006801

Total number of triples: 57.